147 related articles for article (PubMed ID: 37818040)
1.
Zhan X; Zuo Q; Huang G; Qi Z; Wang Y; Zhu S; Zhong Y; Xiong Y; Chen T; Tan B
Front Cell Infect Microbiol; 2023; 13():1236272. PubMed ID: 37818040
[TBL] [Abstract][Full Text] [Related]
2. GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway.
Feng Y; Le F; Tian P; Zhong Y; Zhan F; Huang G; Hu H; Chen T; Tan B
J Cancer; 2021; 12(5):1386-1397. PubMed ID: 33531984
[No Abstract] [Full Text] [Related]
3. Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway.
Yu Y; Liu W; Zhan X; Zhong Y; Feng Y; Cao Q; Tan B
Am J Transl Res; 2022; 14(3):2051-2062. PubMed ID: 35422913
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.
Chambers LM; Esakov Rhoades EL; Bharti R; Braley C; Tewari S; Trestan L; Alali Z; Bayik D; Lathia JD; Sangwan N; Bazeley P; Joehlin-Price AS; Wang Z; Dutta S; Dwidar M; Hajjar A; Ahern PP; Claesen J; Rose P; Vargas R; Brown JM; Michener CM; Reizes O
Cancer Res; 2022 Dec; 82(24):4654-4669. PubMed ID: 36206317
[TBL] [Abstract][Full Text] [Related]
5. Unintended Consequences of Antibiotic Therapy on the Microbiome Delivers a Gut Punch in Ovarian Cancer.
Hawkins SM; Nephew KP
Cancer Res; 2022 Dec; 82(24):4511-4512. PubMed ID: 36524345
[TBL] [Abstract][Full Text] [Related]
6. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.
Liu YK; Jia YJ; Liu SH; Ma J
Cancer Chemother Pharmacol; 2021 Mar; 87(3):405-414. PubMed ID: 33392640
[TBL] [Abstract][Full Text] [Related]
7. Tripterygium glycosides reverse chemotherapy resistance in ovarian cancer by targeting the NRF2/GPX4 signal axis to induce ferroptosis of drug-resistant human epithelial ovarian cancer cells.
Ma B; Zhong Y; Chen R; Zhan X; Huang G; Xiong Y; Tan B
Biochem Biophys Res Commun; 2023 Jul; 665():178-186. PubMed ID: 37163938
[TBL] [Abstract][Full Text] [Related]
8. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
9. TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis.
Li C; Wang Q; Luo Y; Xiang J
Anal Cell Pathol (Amst); 2022; 2022():5632164. PubMed ID: 36247876
[TBL] [Abstract][Full Text] [Related]
10. Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells.
Luo Y; Gui R
J Gynecol Oncol; 2020 Sep; 31(5):e75. PubMed ID: 32808501
[TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
[TBL] [Abstract][Full Text] [Related]
12. [Effects of glycosides of Tripterygium wilfordii and Cistanche deserticola on the fertility of male mice].
Li J; Huang D; He LQ
Zhonghua Nan Ke Xue; 2009 Jun; 15(6):569-72. PubMed ID: 19594001
[TBL] [Abstract][Full Text] [Related]
13. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer].
Shi L; Yu H; Zhang W; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735
[TBL] [Abstract][Full Text] [Related]
14. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.
Wang Y; Yan C; Qi J; Liu C; Yu J; Wang H
Mol Cell Biochem; 2022 Jan; 477(1):307-317. PubMed ID: 34716858
[TBL] [Abstract][Full Text] [Related]
15. Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.
Zhang X; Hong S; Yang J; Liu J; Wang Y; Peng J; Wang H; Hong L
Anticancer Drugs; 2023 Jan; 34(1):29-43. PubMed ID: 35946506
[TBL] [Abstract][Full Text] [Related]
16. Effects of Multi-glycosides of Tripterygium wilfordiion in the Treatment of Sjögren's Syndrome in the Non-obese Diabetic Mouse Model.
Li CL; He J; Li ZG; Zheng LW; Hua H
Chin J Dent Res; 2015; 18(2):95-101. PubMed ID: 26167547
[TBL] [Abstract][Full Text] [Related]
17. Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota.
Lin C; Zeng Z; Lin Y; Wang P; Cao D; Xie K; Luo Y; Yang H; Yang J; Wang W; Luo L; Lin H; Chen H; Zhao Y; Shi Y; Gao Z; Liu H; Liu SL
Phytomedicine; 2022 Nov; 106():154401. PubMed ID: 36029647
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of polyglycosides of Tripterygium wilfordii in preventing postoperative recurrence of Crohn disease].
Liao NS; Ren JA; Fan CG; Wang GF; Zhao YZ; Li JS
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):167-9. PubMed ID: 19296254
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analysis reveals novel insights into the mechanism of hepatotoxicity induced by
Miao Y; Zhang Q; Yuan Z; Wang J; Xu Y; Chai Y; Du M; Yu Q; Zhang L; Jiang Z
Front Pharmacol; 2022; 13():1032741. PubMed ID: 36467101
[No Abstract] [Full Text] [Related]
20. Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin.
Xu Q; Liu Y; Wang S; Wang J; Liu L; Xu Y; Qin Y
BMC Cancer; 2022 Jun; 22(1):628. PubMed ID: 35672728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
